Status- (Rx) Only Telehealth consultation required prior to initiation.
What’s Included in Your Care
When clinically appropriate, services may include:
Clinical consultations with a licensed clinician
Clinical review of medical history and relevant health information
Secure clinician messaging through the patient portal
Prescription medications and supplies, when prescribed
Discreet, unbranded shipping directly to your door
Medication & Pharmacy Standards
Compounded medications, when prescribed, are prepared for human use by licensed U.S.-based pharmacies in accordance with applicable USP standards.
All medications are dispensed pursuant to a valid prescription and are not manufactured, marketed, or represented as research-use products. Compounded medications are not FDA-approved.
Telehealth Convenience & Privacy
100% digital intake and clinician consultation
No waiting rooms or in-person visits required
Secure patient portal for care communication
Discreet, unbranded packaging to protect privacy
Important Care Context
GLP-1–based therapies are prescribed only after review by a licensed clinician and may not be appropriate for all individuals. Treatment decisions are based on medical history, clinical assessment, and provider judgment. Individual experiences and responses vary. TRTBOSS provides access to clinician-directed telehealth care and does not guarantee specific outcomes. Fees reflect clinical services, care coordination, and pharmacy fulfillment associated with prescribed therapy and do not guarantee treatment eligibility or prescription issuance. All treatment decisions are made solely by licensed clinicians.
This clinician-directed care option may be considered for adults who:
Meet clinical criteria commonly evaluated by licensed healthcare providers, such as body composition measures (e.g., BMI ranges) or related metabolic health considerations, as determined during individualized medical review
Are being evaluated for GLP-1–based therapy as part of a comprehensive, prescription-only weight-management care plan, when deemed clinically appropriate
Have previously pursued nutrition- and lifestyle-focused approaches and are seeking a medically supervised option within a licensed telehealth care framework
May be considered for compounded GLP-1 therapy, with supportive nutrients such as Glycine, only when determined clinically appropriate by a licensed clinician
Prefer individualized evaluation, structured monitoring, and ongoing follow-up within a clinician-led telehealth care environment
Understand that all treatment decisions are based on licensed clinician judgment, that therapy may not be appropriate for all individuals, and that individual responses and experiences vary
Route:
Administration route (e.g., injectable or oral, when applicable) is determined solely by the prescribing clinician based on individual evaluation, formulation availability, and clinical considerations.
Dosing & Schedule:
Dosage strength, titration schedule, and duration of therapy are determined by a licensed clinician following review of medical history, treatment goals, and response to therapy. Dosing may be adjusted over time based on follow-up evaluations and clinical judgment.
Supportive Nutrients:
When clinically indicated, supportive nutrients such as Glycine may be prescribed as part of the care plan. Inclusion, formulation, and dosing of these nutrients are determined by the clinician and are not included in all treatment plans.
Patient Guidance:
Patients receive clinician guidance on proper use, administration technique (when applicable), and adherence considerations through the care team and patient portal. Patients should not start, stop, or adjust medication or nutrient dosing without clinician approval.
Monitoring & Follow-Up:
Ongoing monitoring, follow-up consultations, and laboratory testing (when indicated) are ordered at the discretion of the prescribing clinician to support safe use and continuity of care.
Active Ingredient
Semaglutide
A prescription GLP-1 receptor agonist prescribed by a licensed clinician as part of a medically supervised weight-management care program.
Supportive Nutrients
Glycine
Included when clinically indicated to support normal metabolic and neurologic pathways.
Inactive Ingredients
Inactive ingredients vary by formulation and dispensing pharmacy and may include pharmaceutical-grade excipients required for stability, delivery, or administration. Exact ingredients are provided by the dispensing pharmacy and reviewed by the prescribing clinician.
Care options aligned to your goals, based on individualized clinical review
Start with an online intake. Clinicians may order and review lab work when clinically appropriate.
Follow-ups and adjustments are guided by a licensed clinician based on symptoms, history, and lab results.
Clinician-guided discussion of options for men’s health concerns, based on your evaluation and medical history.
Reminders, education, and help navigating next steps—so you know what happens before and after your visit.
Confidential support with secure messaging and account access.
Semaglutide is a GLP-1 receptor agonist that acts by engaging the same signaling pathways as the body’s endogenous glucagon-like peptide-1 hormone. GLP-1 signaling plays a role in appetite regulation by influencing central nervous system pathways involved in hunger and satiety, as well as peripheral processes such as gastric emptying. Through these mechanisms, GLP-1 activity is associated with physiological signals that contribute to feelings of fullness and regulated energy intake within clinician-directed care.
Within some medically supervised care plans, supportive nutrients such as glycine may be included when clinically appropriate to support normal physiological pathways during treatment. Glycine is a naturally occurring amino acid involved in protein synthesis, collagen formation, glutathione production, neurotransmitter signaling, bile acid conjugation, and broader cellular metabolic processes.
Together, these components are utilized within a structured, prescription-only care framework to support normal biological processes relevant to metabolic regulation. All elements of care are prescribed and managed by licensed clinicians following individualized medical evaluation, with treatment decisions guided by clinical judgment rather non-prescription approaches.
Get Started TodayAt TRTBOSS Every step is supported through a clinician-led process with independent, U.S. Licensed clinicians. If prescribed, medications are dispensed and shipped by Licensed U.S pharmacies. From expert medical oversight to discreet delivery, We prioritize privacy, secure communications, and clear next steps throughout your experience.
TRTBOSS has truly changed my life. The process was smooth, the team was supportive, and the results speak for themselves. I feel more energetic, confident, and focused than ever. It’s easily the best decision I’ve made for my health.
TRTBOSS has truly changed my life. The process was smooth, the team was supportive, and the results speak for themselves. I feel more energetic, confident, and focused than ever. It’s easily the best decision I’ve made for my health.
TRTBOSS has truly changed my life. The process was smooth, the team was supportive, and the results speak for themselves. I feel more energetic, confident, and focused than ever. It’s easily the best decision I’ve made for my health.
“Better” is subjective to your body’s needs. Wegovy® is an FDA-approved, single-ingredient drug. This is a compounded medication customized with Glycine. It is prescribed for patients who struggle with side effects like fatigue or other side effects, or as clinically directed.
No. This is a custom formulation. We do not offer it as a generic substitute; we offer it as a functional alternative for patients who have a medical necessity for the added ingredients.
Scientific & Clinical References
-GLP-1 Appetite & Satiety Signaling
Study: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM, 2021)
Role: Describes GLP-1 receptor activation and its role in appetite regulation and energy intake pathways.
Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
-GLP-1 & Gastric Emptying
Study: Effect of Semaglutide on Gastric Emptying, Appetite, and Energy Intake (Diabetes, Obesity & Metabolism, 2021)
Role: Explores delayed gastric emptying and satiety signaling associated with GLP-1 activity.
Link: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14280
– GLP-1 Receptor Mechanisms
Study: GLP-1 Receptor: Mechanisms and Advances in Therapy (Signal Transduction & Targeted Therapy, 2024)
Role: Reviews molecular and physiological GLP-1 receptor pathways involved in metabolic regulation.
Link: https://www.nature.com/articles/s41392-024-01931-z
– Glycine Mechanism: Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review. Reviews glycine’s role as a precursor for key metabolites including creatine, glutathione, heme, purines, and porphyrins.https://pmc.ncbi.nlm.nih.gov/articles/PMC5350494/
– Collagen Structure Mechanism: Proline Precursors and Collagen Synthesis: Biochemical Challenges of Nutrient Supplementation and Wound Healing. Describes collagen as approximately one-third glycine, with glycine appearing at every third amino acid position in the collagen structure.https://pmc.ncbi.nlm.nih.gov/articles/PMC5657141/
– Neurological Signaling Mechanism: National Center for Biotechnology Information (NCBI), Basic Neurochemistry: Glycine Receptors. Describes glycine as a major inhibitory neurotransmitter in the central nervous system, especially the spinal cord.https://www.ncbi.nlm.nih.gov/books/NBK28003/
– Metabolic Pathways Mechanism: Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. Reviews glycine’s involvement in biological functions including synthesis of glutathione, purines, creatine, heme-related compounds, and primary bile acids.https://pmc.ncbi.nlm.nih.gov/articles/PMC6627940/
These references describe biological mechanisms of GLP-1 receptor agonists, vitamin B12, and glycine. They do not evaluate any specific compounded formulation. Treatment decisions are made by licensed clinicians following individual medical evaluation.
Medical Disclaimer: TRTBOSS facilitates access to medical services provided by independent, licensed physicians. This program utilizes a Compounded formulation of GLP-1 and Glycine. This is a compounded medication and is not FDA-approved. It is not a generic version of Wegovy™ or Ozempic™. Compounded medications do not undergo FDA review for safety, efficacy, or quality. Efficacy Notice: While Semaglutide is proven for weight loss, the specific combination of GLP-1 + Glycine has not been evaluated in clinical trials for superior muscle retention compared to GLP-1 alone. Claims regarding “muscle defense” refer to the mechanism of the individual ingredient (Glycine). Risk Warning: Do not use if you have a history of Medullary Thyroid Carcinoma (MTC) or MEN 2. Rx Only.
Personalized telehealth treatments tailored for you.